Back to Search
Start Over
Association between de novo lipogenesis susceptibility genes and coronary artery disease.
- Source :
-
Nutrition, metabolism, and cardiovascular diseases : NMCD [Nutr Metab Cardiovasc Dis] 2022 Dec; Vol. 32 (12), pp. 2883-2889. Date of Electronic Publication: 2022 Sep 15. - Publication Year :
- 2022
-
Abstract
- Background and Aims: Coronary artery disease (CAD) is the principal cause of death in individuals with non-alcoholic fatty liver disease (NAFLD). The aim of this study was to use genetic epidemiology to study the association between de novo lipogenesis (DNL), one of the major pathways leading to NAFLD, and CAD risk.<br />Methods and Results: DNL susceptibility genes were used as instruments and selected using three approaches: 1) genes that are associated with both high serum triglycerides and low sex hormone-binding globulin, both downstream consequences of DNL (unbiased approach), 2) genes that have a known role in DNL (biased approach), and 3) genes that have been associated with serum fatty acids, used as a proxy of DNL. Gene-CAD effect estimates were retrieved from the meta-analysis of CARDIoGRAM and the UK Biobank (∼76014 cases and ∼264785 controls). Effect estimates were clustered using a fixed-effects meta-analysis. Twenty-two DNL susceptibility genes were identified by the unbiased approach, nine genes by the biased approach and seven genes were associated with plasma fatty acids. Clustering of genes selected in the unbiased and biased approach showed a statistically significant association with CAD (OR:1.016, 95%CI:1.012; 1.020 and OR:1.013, 95%CI:1.007; 1.020, respectively), while clustering of fatty acid genes did not (OR:1.004, 95%CI:0.996-1.011). Subsequent exclusion of potential influential outliers did reveal a statistically significant association (OR:1.009, 95%CI:1.000; 1.018).<br />Conclusions: DNL susceptibility genes are associated with an increased risk of CAD. These findings suggest that DNL may be involved in the pathogenesis of CAD and favor further development of strategies that target NAFLD through DNL.<br />Competing Interests: Declaration of competing interest The authors declare that there is no competing interests.<br /> (Copyright © 2022 The Author(s). Published by Elsevier B.V. All rights reserved.)
- Subjects :
- Humans
Lipogenesis genetics
Liver metabolism
Fatty Acids metabolism
Non-alcoholic Fatty Liver Disease diagnosis
Non-alcoholic Fatty Liver Disease epidemiology
Non-alcoholic Fatty Liver Disease genetics
Coronary Artery Disease diagnosis
Coronary Artery Disease epidemiology
Coronary Artery Disease genetics
Subjects
Details
- Language :
- English
- ISSN :
- 1590-3729
- Volume :
- 32
- Issue :
- 12
- Database :
- MEDLINE
- Journal :
- Nutrition, metabolism, and cardiovascular diseases : NMCD
- Publication Type :
- Academic Journal
- Accession number :
- 36182335
- Full Text :
- https://doi.org/10.1016/j.numecd.2022.09.003